newsfilter
← Latest News
ACCESS Newswire·

Aytu BioPharma to Report Fiscal 2027 First Quarter Operational and Financial Results on November 16, 2026

  • Aytu BioPharma, Inc. will report fiscal 2027 first-quarter operational & financial results after market close on Monday, November 16, 2026.
  • A conference call & webcast to review results & host a Q&A session is scheduled for 4:30 p.m. Eastern time on November 16, 2026.
  • Call-in numbers are (888) 506-0062 (US) or +1 (973) 528-0011 (international) using participant access code 943905.
  • The webcast will be live & archived at https://www.webcaster5.com/Webcast/Page/2142/54649 or via the Investors section of aytubio.com.
  • A teleconference replay will be available until November 30, 2026, at (877) 481-4010 (US) or +1 (919) 882-2331 (international) using replay access code 54649.
  • Aytu BioPharma develops medicines for central nervous system diseases, including EXXUA (gepirone) for major depressive disorder & treatments for ADHD.
  • Investor contact for Aytu is Ryan Selhorn (CFO) at rselhorn@aytubio.com, & external contact is Robert Blum of Lytham Partners at aytu@lythampartners.com.
Company
Aytu BioPharma, Inc.
Keywords
Healthcare & Pharmaceutical, Conference Call